This topic contains a solution. Click here to go to the answer

Author Question: A patient who is receiving methotrexate for severe rheumatoid arthritis develops a megaloblastic ... (Read 107 times)

colton

  • Hero Member
  • *****
  • Posts: 627
A patient who is receiving methotrexate for severe rheumatoid arthritis develops a megaloblastic anemia. The nurse will anticipate teaching the patient about increasing oral intake of
 
  a. iron.
  b. folic acid.
  c. cobalamin (vitamin B12).
  d. ascorbic acid (vitamin C).

Question 2

Which menu choice indicates that the patient understands the nurse's teaching about best dietary choices for iron-deficiency anemia?
 
  a. Omelet and whole wheat toast
  b. Cantaloupe and cottage cheese
  c. Strawberry and banana fruit plate
  d. Cornmeal muffin and orange juice



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amy.lauersdorf90

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

ANS: B
Methotrexate use can lead to folic acid deficiency. Supplementation with oral folic acid supplements is the usual treatment. The other nutrients would not correct folic acid deficiency, although they would be used to treat other types of anemia.

Answer to Question 2

ANS: A
Eggs and whole grain breads are high in iron. The other choices are appropriate for other nutritional deficiencies but are not the best choice for a patient with iron-deficiency anemia.




colton

  • Member
  • Posts: 627
Reply 2 on: Jun 25, 2018
Wow, this really help


bdobbins

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

For a complete list of videos, visit our video library